In vitro drug sensitivity and clinical efficacy of the HAG regimen in pediatric AML
The HAG regimen demonstrates high efficacy and holds great promise for pediatric AML. It achieves survival outcomes comparable to more intensive regimens while offering the significant advantage of reduced toxicity.
Authors
- Wenhui Yan (ORCID: https://orcid.org/0000-0001-6976-0137)
- Liping Shang
- Tian Xia
- Diying Shen (ORCID: https://orcid.org/0000-0002-2870-1154)
- Jingying Zhang (ORCID: https://orcid.org/0000-0001-8929-6669)
Institutions
- Children's Hospital of Zhejiang University (CN)
- National Center For Child Health and Development (JP)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/oncolo/oyaf340
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00